Suppr超能文献

《进食评估工具-10 鉴别吞咽安全性和效率损伤的能力》

Discriminant Ability of the Eating Assessment Tool-10 to Detect Swallowing Safety and Efficiency Impairments.

机构信息

Aerodigestive Research Core Laboratory, University of Florida, Gainesville, Florida, U.S.A.

Department of Speech, Language, and Hearing Sciences, University of Florida, Gainesville, Florida, U.S.A.

出版信息

Laryngoscope. 2022 Dec;132(12):2319-2326. doi: 10.1002/lary.30043. Epub 2022 Feb 9.

Abstract

OBJECTIVES/HYPOTHESIS: Quick, sensitive dysphagia screening tools are necessary to identify high-risk patients for further evaluation in busy multidisciplinary amyotrophic lateral sclerosis (ALS) clinics. We examined the relationship between self-perceived dysphagia using the validated Eating Assessment Tool-10 (EAT-10) and videofluoroscopic analysis of swallowing safety and efficiency.

STUDY DESIGN

Prospective, observational, longitudinal study.

METHODS

Individuals with ALS completed the EAT-10 and a videofluoroscopic swallowing study. Duplicate, independent, blinded analyses of the validated Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) scale were performed to index swallowing safety and efficiency (mild dysphagia: DIGEST ≥ 1, moderate dysphagia: DIGEST ≥ 2). A between-groups analysis of variance with Games-Howell test for post-hoc pairwise comparisons was performed to examine EAT-10 scores across dysphagia severity levels. Receiver operator characteristic curve analysis, area under the curve (AUC), sensitivity, specificity, positive-negative predictive values (PPV, NPV), and odds ratios (OR) were derived.

RESULTS

Four hundred and thirty five paired EAT-10 and DIGEST scores were analyzed. Mean EAT-10 score was 8.48 (95% confidence interval [CI]: 7.63-9.33). Individuals with dysphagia demonstrated higher EAT-10 scores (mild: 4.1 vs. 11.3, moderate: 6.0 vs. 17.5, P < .001). Mean EAT-10 scores increased across DIGEST levels (D0: 4.1, D1: 7.9, D2: 15.1, D3: 20.4, D4: 39.0). For mild dysphagia, an EAT-10 cut score of 3 was optimal: AUC 0.74 (95% CI: 0.69-0.78; sensitivity: 77%; specificity: 53%; PPV: 71%; NPV: 60%; OR: 3.5). An EAT-10 cut score of 7 optimized detection of moderate dysphagia: AUC 0.83 (95% CI: 0.78-0.87; sensitivity: 81%; specificity: 66%; PPV: 39%; NPV: 93%; OR: 8.1).

CONCLUSION

The EAT-10 is an easy-to-administer dysphagia screening tool with good discriminant ability for use in ALS clinics.

LEVEL OF EVIDENCE

2 Laryngoscope, 132:2319-2326, 2022.

摘要

目的/假设:快速、敏感的吞咽障碍筛查工具对于在繁忙的多学科肌萎缩侧索硬化(ALS)诊所中识别高危患者进行进一步评估是必要的。我们研究了使用经过验证的饮食评估工具-10(EAT-10)评估的自我感知吞咽障碍与吞咽安全性和效率的视频荧光检查之间的关系。

研究设计

前瞻性、观察性、纵向研究。

方法

ALS 患者完成 EAT-10 和视频荧光吞咽研究。对经过验证的动态成像吞咽毒性分级(DIGEST)量表进行重复、独立、盲法分析,以评估吞咽安全性和效率(轻度吞咽困难:DIGEST≥1,中度吞咽困难:DIGEST≥2)。使用方差分析进行组间分析,并进行 Games-Howell 检验进行事后两两比较,以检查 EAT-10 评分在不同吞咽困难严重程度水平上的差异。得出受试者工作特征曲线分析、曲线下面积(AUC)、灵敏度、特异性、阳性预测值(PPV)、阴性预测值(NPV)和优势比(OR)。

结果

分析了 435 对 EAT-10 和 DIGEST 评分。平均 EAT-10 评分为 8.48(95%置信区间[CI]:7.63-9.33)。有吞咽困难的患者 EAT-10 评分较高(轻度:4.1 分 vs. 11.3 分,中度:6.0 分 vs. 17.5 分,P<.001)。EAT-10 评分随着 DIGEST 水平的升高而升高(D0:4.1,D1:7.9,D2:15.1,D3:20.4,D4:39.0)。对于轻度吞咽困难,EAT-10 评分 3 分为最佳截断值:AUC 0.74(95%CI:0.69-0.78;灵敏度:77%;特异性:53%;PPV:71%;NPV:60%;OR:3.5)。EAT-10 评分 7 分可优化中度吞咽困难的检出:AUC 0.83(95%CI:0.78-0.87;灵敏度:81%;特异性:66%;PPV:39%;NPV:93%;OR:8.1)。

结论

EAT-10 是一种易于管理的吞咽障碍筛查工具,在 ALS 诊所中具有良好的鉴别能力。

证据水平

2 级喉镜,132:2319-2326,2022。

相似文献

1
Discriminant Ability of the Eating Assessment Tool-10 to Detect Swallowing Safety and Efficiency Impairments.
Laryngoscope. 2022 Dec;132(12):2319-2326. doi: 10.1002/lary.30043. Epub 2022 Feb 9.
2
Discriminant ability of the Eating Assessment Tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis.
Neurogastroenterol Motil. 2016 Jan;28(1):85-90. doi: 10.1111/nmo.12700. Epub 2015 Oct 28.
4
Tongue strength, dysphagia questionnaire, pharyngeal secretions and FEES findings in dysphagia management in amyotrophic lateral sclerosis.
Auris Nasus Larynx. 2021 Aug;48(4):672-682. doi: 10.1016/j.anl.2020.10.007. Epub 2020 Oct 24.
5
Discriminant ability of the 3-ounce water swallow test to detect aspiration in amyotrophic lateral sclerosis.
Neurogastroenterol Motil. 2022 Jul;34(7):e14310. doi: 10.1111/nmo.14310. Epub 2021 Dec 22.
6
Profiles of Dysarthria and Dysphagia in Individuals With Amyotrophic Lateral Sclerosis.
J Speech Lang Hear Res. 2023 Jan 12;66(1):154-162. doi: 10.1044/2022_JSLHR-22-00312. Epub 2022 Dec 16.
7
Swallowing Safety and Efficiency Impairment Profiles in Individuals with Amyotrophic Lateral Sclerosis.
Dysphagia. 2022 Jun;37(3):644-654. doi: 10.1007/s00455-021-10315-2. Epub 2021 May 26.
8
Functional Lingual Pressure Thresholds for Swallowing Safety and Efficiency Impairments in Amyotrophic Lateral Sclerosis.
Dysphagia. 2023 Apr;38(2):676-685. doi: 10.1007/s00455-022-10499-1. Epub 2022 Jul 30.
9
Diagnostic utility of different dysphagia screening tools to detect dysphagia in individuals with amyotrophic lateral sclerosis.
Neurol Sci. 2023 Nov;44(11):3919-3927. doi: 10.1007/s10072-023-06918-2. Epub 2023 Jun 27.
10
Relationship between pulmonary, cough, and swallowing functions in individuals with amyotrophic lateral sclerosis.
Muscle Nerve. 2024 Jul;70(1):140-147. doi: 10.1002/mus.28113. Epub 2024 May 14.

引用本文的文献

1
The Current State and Future Directions of Swallowing Care in Amyotrophic Lateral Sclerosis.
Curr Phys Med Rehabil Rep. 2023 Jun;11(2):199-211. doi: 10.1007/s40141-023-00396-5. Epub 2023 Apr 18.
2
Construct Validity of the Amyotrophic Lateral Sclerosis Bulbar Dysfunction Index-Remote.
Am J Speech Lang Pathol. 2025 Jul 10;34(4):2189-2211. doi: 10.1044/2025_AJSLP-24-00489. Epub 2025 Jun 3.
4
Validation of the Swedish Eating Assessment Tool, S-EAT-10, for patients with head and neck cancer.
Sci Rep. 2025 Apr 16;15(1):13109. doi: 10.1038/s41598-025-97170-5.
5
Validation of the Dynamic Imaging Grade of Swallowing Toxicity for Amyotrophic Lateral Sclerosis.
Neurogastroenterol Motil. 2025 Jun;37(6):e70008. doi: 10.1111/nmo.70008. Epub 2025 Mar 3.
6
Association between dysphagia and social isolation in community-dwelling older people.
Eur Geriatr Med. 2025 Apr;16(2):605-613. doi: 10.1007/s41999-024-01140-5. Epub 2025 Jan 4.
7
Dysphagia is a risk factor of malnutrition in X-linked Dystonia-Parkinsonism.
Clin Park Relat Disord. 2024 Nov 17;11:100282. doi: 10.1016/j.prdoa.2024.100282. eCollection 2024.
9
Eating Assessment Tool (EAT-10) Scores to Detect Self-Reported Dysphagia in Brazilians.
Dysphagia. 2023 Dec;38(6):1609-1614. doi: 10.1007/s00455-023-10588-9. Epub 2023 Jun 5.
10
The discriminant ability of the eating assessment tool-10 questionnaire to detect residue and aspiration in patients with mixed etiology of dysphagia.
Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3757-3763. doi: 10.1007/s00405-023-07987-x. Epub 2023 Apr 25.

本文引用的文献

1
Swallowing Safety and Efficiency Impairment Profiles in Individuals with Amyotrophic Lateral Sclerosis.
Dysphagia. 2022 Jun;37(3):644-654. doi: 10.1007/s00455-021-10315-2. Epub 2021 May 26.
2
Correlation Between EAT-10 and Aspiration Risk Differs by Dysphagia Etiology.
Dysphagia. 2022 Feb;37(1):11-20. doi: 10.1007/s00455-021-10244-0. Epub 2021 Jan 24.
4
Temporal Analysis of Factors Associated with EAT-10 in Outpatients with Oropharyngeal Dysphagia from a Tertiary Care Clinic.
Dysphagia. 2018 Aug;33(4):457-467. doi: 10.1007/s00455-018-9874-y. Epub 2018 Jan 20.
5
Validation of the Hebrew Version of the Eating Assessment Tool-10 (H-EAT-10).
Folia Phoniatr Logop. 2016;68(6):261-267. doi: 10.1159/000484557. Epub 2017 Dec 12.
6
Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium.
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):311-312. doi: 10.1080/21678421.2017.1404109. Epub 2017 Dec 5.
7
Construct validity of the Eating Assessment Tool (EAT-10).
Disabil Rehabil. 2019 Mar;41(5):549-559. doi: 10.1080/09638288.2017.1398787. Epub 2017 Nov 9.
8
The Eating Assessment Tool-10 Predicts Aspiration in Adults with Stable Chronic Obstructive Pulmonary Disease.
Dysphagia. 2017 Oct;32(5):714-720. doi: 10.1007/s00455-017-9822-2. Epub 2017 Jul 13.
9
The Ability of the Eating Assessment Tool-10 to Detect Aspiration in Patients With Neurological Disorders.
J Neurogastroenterol Motil. 2017 Oct 30;23(4):550-554. doi: 10.5056/jnm16165.
10
Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.
PLoS One. 2017 May 23;12(5):e0177555. doi: 10.1371/journal.pone.0177555. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验